Remdesivir-d5

Cat. No.: IBDI-432347

Remdesivir-d5 is a deuterium labeled Remdesivir. Remdesivir (GS-5734) is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of 2019-nCoV (COVID-19) infection in vitro.

Product Details

Target	DNA/RNA Synthesis | SARS-CoV
Molecular Weight	607.61
Appearance	Solid
Synonyms	GS-5734-d5
SMILES	C[[email protected]](N[[email protected]@](OC1=C([2H])C([2H])=C([2H])C([2H])=C1[2H])(OC[[email protected]]2O[[email protected]@](C#N)(C3=CC=C4C(N)=NC=NN43)[[email protected]](O)[[email protected]@H]2O)=O)C(OCC(CC)CC)=O
Purity	99.86%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Powder: -20°C/3 years; 4°C/2 years In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.